Dr. Yvette D. Marquez

Gabriel Zada, MD, MS, FAANS is Professor of Neurological Surgery at the Keck School of Medicine of the University of Southern California and a nationally recognized leader in brain tumor and skull base surgery. He serves as Surgical Director of the USC Brain Tumor Center, Co-Director of the USC Pituitary Center and Radiosurgery Center, and Vice Chair of Education for the Department of Neurosurgery. He is also Editor-in-Chief of Neurosurgical Focus, an international open-access journal of the Journal of Neurosurgery Publishing Group.Dr. Zada specializes in minimally invasive and endoscopic approaches to complex brain, pituitary, and skull base tumors and has performed more than 3,000 cranial operations during his career. His NIH-funded research program focuses on the genomics and epigenetics of brain and pituitary tumors, advancing precision medicine approaches in neurosurgical oncology.A prolific scholar, Dr. Zada has authored over 350 peer-reviewed publications and several textbooks in neurosurgery. Based on independent academic impact and expertise metrics, FindExpertMD ranks him the #1 neurosurgeon in California for multiple tumor (pituitary, meningioma) and skull base conditions and among the top neurosurgeons globally. Dr. Zada is highly rated in 66 conditions, according to our data. His top areas of expertise are Pituitary Tumor, Hypothalamic Tumor, Brain Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Gamma Knife Radiosurgery.

Marvin Bergsneider is a Neurosurgery provider in Los Angeles, California. Dr. Bergsneider is highly rated in 39 conditions, according to our data. His top areas of expertise are Pituitary Tumor, Hypothalamic Tumor, Brain Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Balloon Sinuplasty.

Dr. Tahseen Mozaffar is a Professor of Neurology, Orthopaedic Surgery and Pathology and Laboratory Medicine at University of California, Irvine. He is the Director of the UC Irvine-MDA ALS and Neuromuscular Center and the Director of the Division of Neuromuscular Diseases. Dr. Mozaffar serves as chair of one of the biomedical committees and the institutional liaison for Trials Innovation Hub for the Center for Translational Sciences Award (CTSA) at University of California, Irvine. He is the Principal Investigator for UCI-NEXT, the NeuroNEXT award to the University of California, Irvine, one of 25 such NeuroNEXT sites funded by the NINDS/NIH.. Dr. Mozaffar is highly rated in 31 conditions, according to our data. His top areas of expertise are Pompe Disease, Inclusion Body Myositis, Myositis, Myasthenia Gravis, and Thymectomy.